Keyword: University of Michigan
AstraZeneca’s AZD1775 extended median survival in pancreatic cancer when combined with chemo and radiation in a phase 1 trial.
Using single-cell RNA sequencing, scientists have uncovered new cellular changes that could drive the progression of NASH.
An enzyme that works on leptin receptors and a receptor protein called MC3R could be anti-obesity drug targets.
Last week’s biotech discoveries include a gut-coating pill that lowers glucose and prostate-tumor test to predict a good response to immunotherapy.
Transplanting pancreatic islets, along with a hydrogel that "trains" immune cells to accept them, could translate to a cure for Type 1 diabetes.
Biotech discoveries over the past week included a key molecule in nerve cells in Parkinson’s and insights into the brain’s role in obesity.
Scientists believe they've discovered a novel gene that can be inhibited with antisense technology to treat cancer.
Worm models show that a previously dismissed process in genetic coding could explain why quitting smoking is so hard.
University of Michigan scientists made some surprising discoveries when they did a detailed genetic analysis of metastatic tumors from 500 patients.
UCSD scientists are repurposing the anti-inflammatory drug amlexanox to treat Type 2 diabetes.